UMBILICAL-DERIVED STEM CELL THERAPY — LOCAL INJECTION ONLY.
Researchers are investigating umbilical cord-derived mesenchymal stem cells (UC-MSCs) for their potential to support tissue repair, control inflammation, and aid recovery from musculoskeletal problems. At EverHealth Institute in Orlando, FL, we offer local, targeted UC-MSC injections strictly as an experimental service under direct physician supervision — following rigorous informed-consent, safety, and compliance protocols.
These cells are obtained from screened, ethically sourced umbilical cord tissue processed in regulated facilities, as part of physician-directed MSC therapy models currently under active study.
WHAT THE EVIDENCE SHOWS FOR LOCAL MSC INJECTION.
Local UC-MSC injections have been studied — though still considered investigational — primarily in orthopedic and tissue-healing settings. Published human studies suggest potential benefit in the following areas when injected locally under sterile technique.
Knee Osteoarthritis & Cartilage Degeneration
Randomized and prospective studies show UC-MSC injections may improve pain and function scores, support cartilage quality on MRI, and reduce inflammatory signaling. (Lamo-Espinosa et al., Transplantation 2016; Gupta et al., Stem Cells International)
Tendon & Soft Tissue Repair
Pilot and preliminary studies indicate possible assistance in tendon recovery — including rotator cuff pathology, Achilles tendinopathy, and chronic tendon degeneration. Evidence remains early-stage.
Post-Surgery & Injury Recovery
Some studies indicate reduced pain, enhanced mobility, and improved tissue healing markers following MSC use in orthopedic recovery. Small controlled trials also suggest benefit in localized inflammatory joint conditions.
WHAT'S HAPPENING BIOLOGICALLY.
Umbilical-derived MSCs do not become new tissue in humans in routine clinical practice. Current science suggests their benefit is primarily paracrine-mediated — meaning they release growth factors, extracellular vesicles, and cytokines that may improve the local tissue environment. This is mechanistic and investigational — not a guaranteed clinical outcome.
Support Native Repair Cells
Signaling molecules released by UC-MSCs may activate the body's own tissue repair cells, enhancing local healing responses without replacing damaged structures directly.
Calm Inflammatory Signaling
UC-MSCs may modulate immune activity and reduce inflammatory cytokines that drive chronic pain, tissue degradation, and impaired healing in the joint environment.
Improve Local Tissue Environment
Paracrine signals may improve the microenvironment surrounding damaged tissue — creating conditions more favorable to natural repair and regeneration.
Promote Angiogenesis & Matrix Remodeling
Growth factors may stimulate new blood vessel formation and support extracellular matrix remodeling — two processes critical to durable tissue recovery.
SAFETY, SOURCING & OUR STANDARDS.
At EverHealth in Orlando, FL, we use properly sourced biologic materials only from vetted, qualified suppliers. Every patient is fully counseled on risks and alternatives before treatment begins. Your care is always physician-directed and medically supervised.
WHAT ABOUT IV SYSTEMIC STEM CELL INFUSION?
We believe in science first and honesty always. Systemic IV MSC infusion remains earlier-stage research with important limitations — and EverHealth presently limits MSC use to local, targeted injection under medical oversight.
Human trials using IV MSC infusions exist in autoimmune, inflammatory, pulmonary, and metabolic research settings
Some studies show reductions in CRP and inflammatory cytokines — particularly in autoimmune-related disease and graft-versus-host disease
Systemic IV MSC infusion remains earlier-stage research
Long-term safety and optimal dosing remain under active investigation
No IV MSC product is FDA-approved for general clinical use
Risks may include immune reaction, infusion response, infection, or theoretical clotting and embolic risks
EverHealth presently limits MSC use to local, targeted injection under medical oversight — unless part of a formal approved research environment. This reflects our commitment to evidence-anchored, responsible regenerative medicine delivered with clinical integrity.
WHO MAY BE CONSIDERED FOR TREATMENT.
Patients seeking support in the following areas — after failing conservative therapy — may be considered following physician evaluation at our Orlando, FL practice. We work collaboratively with orthopedic, rheumatology, and specialty partners as appropriate.
Orthopedic pain support following inadequate response to conventional treatment
Cartilage health support in early to moderate degenerative joint disease
Tendon or soft-tissue recovery support after standard therapy has not achieved adequate results
Anti-inflammatory modulation at a localized site under physician assessment
Stem cell therapy at EverHealth Institute is investigational and is not FDA-approved to diagnose, treat, cure, or prevent any disease. Results vary. Risks and alternatives will be discussed thoroughly prior to treatment. This transparency ensures patients receive innovative care delivered ethically, responsibly, and safely in Orlando, FL.
Frequently Asked Questions
Is stem cell therapy FDA-approved?
Are results guaranteed?
No. Outcomes vary and may be modest or absent.
Is this covered by insurance?
Typically no experimental therapy is self-pay.
Is the material ethical & safe?
We only use screened, ethically obtained umbilical-derived biologics processed in regulated facilities.
Can I use this instead of surgery?
This is not a surgical substitute and should be discussed with your surgeon.